Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2036

Annual patent cliff calendar for 2036 — US pharmaceutical patents by expiration date.

Patents
1,428

Quick answer

1,428 indexed pharmaceutical patents have expiration dates in 2036. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9493544

    Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

    Nektar Therapeutics · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9493527

    Compositions and methods for the delivery of nitric oxide

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9493526

    Compositions and methods for the delivery of oxygen

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9493467

    PI3 kinase antagonists

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9493482

    Compounds and methods for preventing or treating sensory hair cell death

    Oricula Therapeutics LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9493484

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9493429

    Substituted benzoxazoles and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9492569

    Antibodies that bind integrin alpha-V beta-8

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9493738

    Method for producing high yield attenuated Salmonella strains

    Vaximm AG · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9492781

    Portable oxygen enrichment device and method of use

    SEPARATION DESIGN GROUP LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9492523

    Broadly protective Shigella vaccine based on type III secretion apparatus proteins

    The Board of Regents for Oklahoma State University · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9492480

    Iron oxide nanoparticles for use in treating non-infectious inflammatory disorders

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9492405

    Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9492520

    Fusion molecule based on novel TAA variant

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9493626

    Dispersions comprising discrete carbon nanotube fibers

    MOLECULAR REBAR DESIGN, LLC · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9492484

    Cardiosphere derived cell population and methods of use

    The Regents of the University of California · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9492490

    Pest control using natural pest control agent blends

    TYRATECH, INC. · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9492477

    Compositions comprising citrate and applications thereof

    The Board of Regents of the University of Texas System · Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. EP 3093014

    CABAZITAXEL UND DESSEN VERWENDUNG ZUR BEHANDLUNG VON KREBS

    AVENTIS PHARMA SA [FR] · Granted Wed Nov 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Nov 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9497945

    Humanized dipeptidyl peptidase IV (DPP4) animals

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9502638

    Method of manufacturing flexible piezoelectric structures

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9498445

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    RedHill Biopharma Ltd. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9499818

    Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene

    BIOMARIN TECHNOLOGIES B.V. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9499608

    Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS penetration

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9499554

    Anti-influenza compositions and methods

    BioCryst Pharmaceuticals, Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9498471

    Use of CDK9 inhibitors to reduce cartilage degradation

    The Regents of the University of California · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9498571

    Nitric oxide delivery devices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9498432

    Injectable flowable composition comprising buprenorphine

    Indivior UK Limited · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9498479

    Dihydropyrimidine compounds and their application in pharmaceuticals

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9498511

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9498468

    Rhinitis treatment regimens

    Pharmaceutical Design, LLC · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9498533

    Drug delivery compositions and methods

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9498537

    Method of enhancing efficacy of blood transfusions

    The Regents of the University of California · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9498566

    Selective cytopheresis devices and related methods thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9498529

    Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9498544

    Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents

    Tissue Regeneration Therapeutics Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9502711

    Fabrication of biscrolled fiber using carbon nanotube sheet

    The Board of Regents of the University of Texas System · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9499497

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9499516

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9499494

    Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9499495

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9499568

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9499588

    Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9499597

    Methods and compositions for treating Huntington's disease

    Sangamo Biosciences, Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9499487

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9499583

    Antibacterial antisense oligonucleotide and method

    Sarepta Therapeutics, Inc. · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9499595

    Development of influenza A antivirals

    The Board of Regents of the University of Texas System · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9499606

    Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2036?

1,428 published patents in our USPTO index have expiration dates falling in calendar year 2036.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.